Tyrosine Kinase Inhibitors: all 10,744 studies that test it
Page 92 of 108. Open to participants first (1,949), then studies with results posted, then the rest; newest registration first within each.
- TORI 104 Pre-Surgical DasatinibWithdrawnNCT01410708Phase 2
- Masitinib in Refractory Active Rheumatoid ArthritisTerminatedNCT01410695Phase 2/3
- Erlotinib Versus Vinorelbine/Cisplatin as Adjuvant Treatment in Stage IIIA NSCLC Patients With EGFR MutationsStatus unknownNCT01410214Phase 2
- Palliative Treatments for Patients With Advanced Hepatocellular Carcinoma (HCC)CompletedNCT01409499Phase 4
- Antiandrogen Therapy With or Without Axitinib Before Surgery in Treating Patients With Previously Untreated Prostate Cancer With Known or Suspected Lymph Node MetastasisCompletedNCT01409200Phase 2
- Rotating Pazopanib and Everolimus to Avoid ResistanceCompletedNCT01408004Phase 2
- Erlotinib Versus Gemcitabine/Cisplatin as (Neo)Adjuvant Treatment in Non-small Cell Lung CancerStatus unknownNCT01407822Phase 2/3
- Study of Pazopanib, Paclitaxel, and Carboplatin in Patients With Advanced Solid TumorsTerminatedNCT01407562Phase 1
- Nilotinib With Radiation for High Risk ChordomaCompletedNCT01407198Phase 1
- A Study to Assess the Pharmacokinetics of ASP015K in Healthy Male SubjectsCompletedNCT01406132Phase 1
- Feasibility Study to Estimate Number of Patients With Precancerous Areas in Their Airways and the Response to GefitinibTerminatedNCT01405846Phase 2
- Sorafenib in First-line Treatment of Advanced B Child Hepatocellular CarcinomaTerminatedNCT01405573Phase 3
- Gefitinib Versus Vinorelbine/Platinum as Adjuvant Treatment in Stage II-IIIA(N1-N2) NSCLC With EGFR MutationStatus unknownNCT01405079Phase 3
- Drug-drug Interaction Study With Metformin and ImatinibCompletedNCT01404715Phase 1
- Evaluation of Liposomal Curcumin in Healthy VolunteersCompletedNCT01403545Phase 1
- Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer PatientsCompletedNCT01402089Phase 4
- Effect of Rifampin on the Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid TumorsCompletedNCT01401933Phase 1
- Study of an Investigational Drug, ASP3026, in Patients With Solid TumorsCompletedNCT01401504Phase 1
- Efficacy of Nilotinib Versus Imatinib in Ph+ CML in Early CP Who Have a Suboptimal Molecular Response to ImatinibStatus unknownNCT01400074Phase 3
- Sorafenib Maintenance Therapy for Patients With AML After Allogeneic Stem Cell TransplantCompletedNCT01398501Phase 1
- Effects of Gastric pH on the Pharmacokinetics of DasatinibCompletedNCT01398046Phase 1
- Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML)CompletedNCT01397799Phase 1
- A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare TumoursActive, not recruitingNCT01396408Phase 2
- A Trial Looking at Nilotinib to Treat Acral and Mucosal Melanoma Skin Cancer That Has SpreadCompletedNCT01395121Phase 2
- PDGFR Inhibitor Crenolanib in Children/Young Adults With Diffuse Intrinsic Pontine Glioma or Recurrent High-Grade GliomaCompletedNCT01393912Phase 1
- HYPAZ: Hypertension Induced by PazopanibTerminatedNCT01392352Phase 2
- Famitinib in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC)CompletedNCT01392235Phase 2
- Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid TumorsCompletedNCT01391533Phase 1
- A Study to Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML)CompletedNCT01390337Phase 1
- Efficacy and Safety of a Neoadjuvant Treatment in Pancreatic CancerCompletedNCT01389440Phase 2
- Study in Healthy Males to Assess the Bioavailability of 4 Different Fostamatinib TabletsCompletedNCT01387308Phase 1
- A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015KCompletedNCT01387087Phase 1
- Single Dose Study of [14C]-Labelled AMG 706 in Patients With Advanced Solid TumorsCompletedNCT01386866Phase 1
- Pazopanib, Docetaxel, Prednisone ProstateCompletedNCT01385228Phase 1
- Phase I Study of CUDC-101 With Cisplatin and Radiation in Subjects With Head & Neck CancerCompletedNCT01384799Phase 1
- Safety and Preliminary Efficacy of GLPG0634 in Methotrexate-refractory Active Rheumatoid Arthritis PatientsCompletedNCT01384422Phase 2
- Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal CancerCompletedNCT01383343Phase 1
- To Compare Relative Bioavailability of Two Clinical Formulations of Linifanib.CompletedNCT01381341Phase 1
- A Phase 3, Randomized, Double-Blinded, Placebo-Controlled Study of ARQ 197 Plus Erlotinib Versus Placebo Plus ErlotinibTerminatedNCT01377376Phase 3
- Pazopanib in Patients With Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaStatus unknownNCT01377298Phase 2
- A Study of Sorafenib in Patients With Chemonaive Metastatic Uveal MelanomaStatus unknownNCT01377025Phase 2
- Pre-operative 5-Fluorouracil (5-FU) and Sorafenib With External Radiation in Locally Advanced Rectal CancerCompletedNCT01376453Phase 1
- Bioequivalence And Food Effect Study Of Bosutinib In Healthy SubjectsCompletedNCT01374139Phase 1
- First International Randomized Study in Malignant Progressive Pheochromocytoma and ParagangliomaCompletedNCT01371201Phase 2
- Study of Oral AMN107 (Nilotinib) in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Previously Enrolled to CAMN107A2109 TrialCompletedNCT01368523Phase 4
- Pharmacokinetic Interaction Study to Assess the Effect of ASP015K on Mycophenolate Mofetil in Healthy VolunteersCompletedNCT01364987Phase 1
- A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015KCompletedNCT01364974Phase 1
- Cediranib Maleate and Selumetinib Sulfate in Treating Patients With Solid MalignanciesActive, not recruitingNCT01364051Phase 1
- A Phase 1 Study to Evaluate the Effect of Rifampin on the Pharmacokinetics of Tivozanib in Healthy SubjectsCompletedNCT01363804Phase 1
- A Phase 1 Study to Evaluate The Effect of Ketoconazole on the Pharmacokinetics of Tivozanib in Healthy SubjectsCompletedNCT01363778Phase 1
- Assess the Efficacy of Whole Brain Radiation Therapy in Lung Cancer Patients With Brain MetastasisTerminatedNCT01363557Not applicable
- TRICC-C (AIO-KRK-0111): BIBF 1120 Versus Placebo in Patients Receiving Oxaliplatin Plus Fluorouracil and Leucovorin (mFOLFOX6) for Advanced, Chemorefractory Metastatic Colorectal Cancer (mCRC)CompletedNCT01362361Phase 2
- Pilot Clinical Trial of Pazopanib in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or at Initial Diagnosis When no Intensive Treatment is PossibleCompletedNCT01361334Phase 2
- Palliative Treatment of Hepatocellular Carcinoma in Patient With CHILD B CirrhosisCompletedNCT01357486Phase 2
- A Phase 2, Open-Label Study of Amuvatinib in Combination With Platinum-Etoposide Chemotherapy in Small Cell Lung CancerCompletedNCT01357395Phase 2
- Effects of Administration of Fostamatinib on Blood Concentrations of Digoxin in Healthy SubjectsCompletedNCT01355354Phase 1
- Hepatocellular Carcinoma (HCC) Transarterial Chemoembolisation (TACE) +AxitinibCompletedNCT01352728Phase 2
- MEK162 and RAF265 in Adult Patients With Advanced Solid Tumors Harboring RAS or BRAFV600E MutationsCompletedNCT01352273Phase 1
- Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's MacroglobulinemiaCompletedNCT01351935Phase 1
- BIBF 1120 and RAD001 in Solid Tumors - Phase ICompletedNCT01349296Phase 1
- Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast CancerWithdrawnNCT01349088Phase 1/2
- Lenalidomide in Combination With a Fixed Dose of Sorafenib for the Treatment of Hepatocellular CarcinomaTerminatedNCT01348503Phase 1
- Turmeric Effect on Reduction of Serum Prolactin and Related Hormonal Change and Adenoma Size in Prolactinoma PatientsStatus unknownNCT01344291Phase 1
- A Study of Complete Molecular Response for Chronic Myeloid Leukemia in Chronic Phase Patients, Treated With DasatinibCompletedNCT01342679Phase 2
- Sorafenib in Elderly Patients With Metastatic Renal Cell CarcinomaTerminatedNCT01342627Phase 2
- Study of Pazopanib and Vorinostat in Patients With Advanced MalignanciesCompletedNCT01339871Phase 1
- Open Label Regorafenib Study to Evaluate Cardiovascular Safety Parameters, Tolerability, and Anti-tumor ActivityCompletedNCT01339104Phase 1
- Pilot Study Sorafenib as Bridge to Orthotopic Liver Transplantation (OLT)TerminatedNCT01337492Early Phase 1
- A Trial of Cediranib in the Treatment of Patients With Alveolar Soft Part Sarcoma (CASPS)Status unknownNCT01337401Phase 2
- GLPG0778: Multiple Ascending Oral Doses, Pharmacokinetic, Safety, and Pharmacodynamic StudyCompletedNCT01336244Phase 1
- A Study of BI 853520 in Patients With Various Types of Advanced or Metastatic CancerCompletedNCT01335269Phase 1
- Temsirolimus + Sorafenib in Advanced Hepatocellular Carcinoma (HCC)WithdrawnNCT01335074Phase 1/2
- Study of Axitinib in Patients With Unresectable Hepatocellular CarcinomaCompletedNCT01334112Phase 2
- Study of the Combination of Axitinib Plus Everolimus in Patients With Malignant Advanced Solid TumorsCompletedNCT01334073Phase 1
- Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation TherapyWithdrawnNCT01332279Phase 1
- Curcumin PharmacokineticsCompletedNCT01330810Phase 1
- A Study to Compare Two Different Tablet Formulations of AZD8931 in Healthy Males and FemalesCompletedNCT01330758Phase 1
- Study of INC280 in Patients With c-MET Dependent Advanced Solid TumorsCompletedNCT01324479Phase 1
- Transarterial Chemoembolization Using Doxorubicin Beads With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By SurgeryStatus unknownNCT01324076Phase 3
- Efficacy of Pazopanib in Gastrointestinal Stromal Tumors (GIST)CompletedNCT01323400Phase 2
- Experience of Erlotinib in Patients With Advanced Non-Small Cell Lung CancerSuspendedNCT01320501Phase 4
- Curcumin + Aminosalicylic Acid (5ASA) Versus 5ASA Alone in the Treatment of Mild to Moderate Ulcerative ColitisCompletedNCT01320436Phase 3
- BIBW 2992 (Afatinib) for the Treatment of Patients With HER2-positive, Hormone-refractory Prostate CancerTerminatedNCT01320280Phase 2
- Breast Cancer Study: Paclitaxel Versus Paclitaxel Plus Sorafenib in Second- or Third-line TreatmentCompletedNCT01320111Phase 2
- Effect of Ketoconazole on Regorafenib (BAY73-4506) PharmacokineticsCompletedNCT01318265Phase 1
- A Single Center, Open-label, Randomized, Two-period Crossover Food Effect Study of Single Doses of Tivozanib (AV-951) in Healthy SubjectsCompletedNCT01316848Phase 1
- A Study of ARRY-382 in Patients With Selected Advanced or Metastatic CancersCompletedNCT01316822Phase 1
- Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell CancerCompletedNCT01316757Phase 2
- Glivec in Prostate Cancer Patients With Rising PSA Following Radical ProstectomyCompletedNCT01316458Phase 2
- Gleevec as Maintenance Therapy After Cytogenetic Response With Nilotinib in Newly Diagnosed Chronic Myelogenous LeukemiaCompletedNCT01316250Not applicable
- Effects of Administration of Fostamatinib on Blood Concentrations of Warfarin in Healthy SubjectsCompletedNCT01311622Phase 1
- Study of Dasatinib to Treat Philadelphia Positive Acute Lymphoblastic LeukemiaCompletedNCT01310010Phase 2
- Effects of Administration of Fostamatinib on Blood Concentrations of Pioglitazone in Healthy SubjectsCompletedNCT01309854Phase 1
- Study Evaluating Two Loading Regimens of Sunitinib or Bevacizumab Alternating With Cisplatin and Gemcitabine as Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC)CompletedNCT01309633Phase 2
- Study of Preoperative Weekly Paclitaxel and Carboplatin With Lapatinib (Tykerb®) in Patients With ErbB2-Positive Stage I-III Breast CancerStatus unknownNCT01309607Phase 2
- Study of Continuous Dosing of Sunitinib in Non GIST Sarcomas With Concomitant RadiotherapyCompletedNCT01308034Phase 1
- A Trial of Tivozanib (AV-951) in Combination With Capecitabine (Xeloda®) in Subjects With Advanced Solid TumorsCompletedNCT01306630Phase 1
- A Study of MM-111 in Combination With Multiple Treatments in Patients With HER2 Positive CancerCompletedNCT01304784Phase 1
- Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or MelanomaActive, not recruitingNCT01303341Phase 1
- Safety and Efficacy Study of Gemcitabine-erlotinib Versus Gemcitabine-erlotinib-capecitabine in Patients With Metastatic Pancreatic CancerCompletedNCT01303029Phase 2